Deborah Hurst

2.3k citations

32 papers · 1.8k indexed · h-index 17

Impact in

Hematology top 1%
- Iron Metabolism and Disorders
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Acute Myeloid Leukemia Research
- Blood groups and transfusion
Genetics top 1%
- Hemoglobinopathies and Related Disorders

Papers in ⓘ

Hematology 18
- Hemophilia Treatment and Research 8
- Iron Metabolism and Disorders 6
- Platelet Disorders and Treatments 5
- Blood groups and transfusion 4
Genetics 14
- Hemoglobinopathies and Related Disorders 6
- Chronic Lymphocytic Leukemia Research 6

Co-authors: Bertram H. Lubin (5 shared papers)Klara Kleman (5 shared papers)Elliott Vichinsky (5 shared papers)Ann N. Earles (2 shared papers)Khang Hoang (3 shared papers)Sacha Satram‐Hoang (3 shared papers)Carolina Reyes (3 shared papers)Bruno C. Medeiros (3 shared papers)
Journals: Blood (11 papers)The Journal of Pediatrics (3 papers)PEDIATRICS (3 papers)Clinical Cancer Research (2 papers)Haemophilia (2 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Deborah Hurst

32 papers receiving 1.7k citations

Peers

Countries citing papers authored by Deborah Hurst

Since Specialization

Citations

This map shows the geographic impact of Deborah Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Hurst more than expected).

Fields of papers citing papers by Deborah Hurst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Hurst. The network helps show where Deborah Hurst may publish in the future.

Co-authors

The 25 scholars most cited alongside Deborah Hurst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deborah Hurst Line = papers co-authored together Deborah Hurst links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Newborn Screening for Sickle Cell Disease: Effect on Mortality PEDIATRICS ·Elliott Vichinsky, Deborah Hurst, Ann N. Earles, Klara Kleman, Bertram H. Lubin	1989	249
2	Newborn Screening for Sickle Cell Disease: Effect on Mortality PEDIATRICS ·Elliott Vichinsky, Deborah Hurst, Ann N. Earles, Klara Kleman, Bertram H. Lubin	1988	235
3	Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States Annals of Hematology ·Bruno C. Medeiros, Sacha Satram‐Hoang, Deborah Hurst, Khang Hoang, Faiyaz Momin, Carolina Reyes	2015	189
4	Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion Blood ·Jerry S. Powell, Margaret V. Ragni, Gilbert White, Jeanne M. Lusher, Carol Hillman-Wiseman, Tom E. Moon, Veronica Cole, Sandhya Ramanathan-Girish, Holger Roehl, Nancy Sajjadi, Douglas J. Jolly, Deborah Hurst	2003	165
5	The Inhibitor Antibody Response Is More Complex in Hemophilia A Patients Than in Most Nonhemophiliacs With Factor VIII Autoantibodies Blood ·Richard Prescott, Hiroaki Nakai, Evgueni L. Saenko, I. Scharrer, Inga Marie Nilsson, John Eric Humphries, Deborah Hurst, Gordon L. Bray, Dorothea Scandella, (unknown)	1997	156
6	A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia Leukemia & lymphoma ·Thomas J. Kipps, Herbert Eradat, Sebastian Grosicki, John Catalano, Walter Cosolo, Iryna Dyagil, Sreeni Yalamanchili, Akiko Chai, Srikumar Sahasranaman, Elizabeth A. Punnoose, Deborah Hurst, Halyna Pylypenko	2015	151
7	Phase I Studies of Interleukin (IL)-2 and Rituximab in B-Cell Non-Hodgkin’s Lymphoma Clinical Cancer Research ·William Larry Gluck, Deborah Hurst, Alan R. Yuen, Alexandra M. Levine, Mark A. Dayton, Jon P. Gockerman, Jennifer B. Lucas, Kimberly Denis-Mize, Barbara Tong, Dawn Navis, A. DiFrancesco, Sandra Milan, Susan E. Wilson, Maurice J. Wolin	2004	127
8	GROWTH RETARDATION IN SICKLE-CELL DISEASE TREATED BY NUTRITIONAL SUPPORT The Lancet ·MelvinB. Heyman, Richard S. Katz, Deborah Hurst, Danny Chiu, ArthurJ. Ammann, Elliott Vichinsky, Barbara Gaffield, Ricardo Castillo, Klara Kleman, Michael Thaler, Bertram H. Lubin	1985	73
9	A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma Clinical Cancer Research ·Khuda Dad Khan, Christos Emmanouilides, Don M. Benson, Deborah Hurst, Pablo Garcia, Glenn Michelson, Sandra Milan, Amy K. Ferketich, Lawrence D. Piro, John P. Leonard, Pierluigi Porcu, Charles F. Eisenbeis, Amy Banks, Lei Chen, John C. Byrd, Michael A. Caligiuri	2006	71
10	Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigation Journal of Thrombosis and Haemostasis ·Jeanne M. Lusher, C F Abildgaard, Steven Arkin, Pier Mannuccio Mannucci, R. Zimmermann, Lawrence A. Schwartz, Deborah Hurst	2004	61
11	Lung function in the elderly. Thorax ·M L Burr, Kirsten Phillips, Deborah Hurst	1985	48
12	Transfusion of infants with activation of erythrocyte T antigen The Journal of Pediatrics ·Roger A. Williams, Evelyn F. Brown, Deborah Hurst, Lawrence C. Franklin	1989	38
13	Anemia and hemoglobinopathies in Southeast Asian refugee children The Journal of Pediatrics ·Deborah Hurst, Barbara S. Tittle, Klara Kleman, Stephen H. Embury, Bertram H. Lubin	1983	24
14	Bleeding Disorders in Noonan Syndrome: Three Case Reports and Review of the Literature The American journal of pediatric hematology/oncology ·Sylvia T. Singer, Deborah Hurst, Joseph E. Addiego	1997	22
15	Epitope specificity and functional characterization of factor VIII inhibitors Advances in experimental medicine and biology ·(unknown), Dorothea Scandella, Craig M. Kessler, Pamela C. Esmon, Deborah Hurst, S Courter, Edward D. Gomperts, Matthew Felch, Richard Prescott	1995	20
16	Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma Leukemia & lymphoma ·Shaker R. Dakhil, Róbert Hermann, Marshall T. Schreeder, Stephanie A. Gregory, Marc Monte, Kevin Windsor, Deborah Hurst, Akiko Chai, Michael Brewster, Paul Richards	2014	19
17	Pharmacokinetics and Pharmacodynamics from a First-in-Human Phase 1 Dose Escalation Study with Antagonist Anti-CD40 Antibody, HCD122 (Formerly CHIR-12.12), in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia. Blood ·John C. Byrd, Ian W. Flinn, Khuda Dad Khan, Thomas J. Kipps, Lea Aukerman, Judith A. Fox, Sandhya Girish, Serge Guzy, Sanela Bilic, Alan M. Solinger, Sherri Dort, Yongyu Wang, Deborah Hurst, Susan O’Brien	2006	17
18	A Phase 1 Dose Escalation Study of a Fully Human, Antagonist Anti-CD40 Antibody, HCD122 (Formerly CHIR-12.12) in Patients with Relapsed and Refractory Multiple Myeloma. Blood ·William Bensinger, Sundar Jagannath, Pamela S. Becker, Kenneth C. Anderson, Edward A. Stadtmauer, Lea Aukerman, Judith A. Fox, Sandhya Girish, Sanela Bilic, Serge Guzy, Alan M. Solinger, Sherri Dort, Yongyu Wang, Deborah Hurst	2006	16
19	Safety and efficacy of solvent/detergent‐treated antihaemophilic factor with an added 80 °C terminal dry heat treatment in patients with haemophilia A Haemophilia ·Jerry S. Powell, Mark Bush, Ewen M. Harrison, C F Abildgaard, Evan Vosburgh, Arthur R. Thompson, Deborah Hurst	2000	15
20	Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group Blood ·PM Mannucci, DB Brettler, LM Aledort, J.M. Lusher, C F Abildgaard, R S Schwartz, Deborah Hurst	1994	15

About Deborah Hurst

Deborah Hurst is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Physiology, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (8 papers), Lymphoma Diagnosis and Treatment (7 papers), Hemoglobinopathies and Related Disorders (6 papers), Iron Metabolism and Disorders (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Platelet Disorders and Treatments (5 papers), Blood groups and transfusion (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Hematology (1.0k citations), Genetics (788 citations), Pediatrics, Perinatology and Child Health (330 citations), Oncology (314 citations) and Immunology (232 citations). Deborah Hurst has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Bertram H. Lubin, Klara Kleman, Elliott Vichinsky, Ann N. Earles, Khang Hoang, Sacha Satram‐Hoang, Carolina Reyes, Bruno C. Medeiros, Jeanne M. Lusher and Dorothea Scandella. Their work appears in journals such as Blood, The Journal of Pediatrics, PEDIATRICS, Clinical Cancer Research and Haemophilia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact